SCHEMBL5301732

SCHEMBL5301732

CCCCCCC[n+]1ccn(CCCC)c1

nearest known ligand 0.58

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.58
HSP90AA1 P07900 2/20 0.58
KMT2A Q03164 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
APAF1 O14727 1/20 0.56
NPC1 O15118 1/20 0.56
PLA2G1B P04054 1/20 0.56
MAPT P10636 1/20 0.56
MAPK1 P28482 1/20 0.56
HTT P42858 1/20 0.56
RAB9A P51151 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
ATG4B Q9Y4P1 1/20 0.56
FDPS P14324 11/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL412476 1.00 MEN1 (0.58) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL5298378 1.00 MEN1 (0.58) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL413208 1.00 MEN1 (0.58) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL413479 1.00 MEN1 (0.58) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL4230960 1.00 MEN1 (0.58) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL5289867 1.00 MEN1 (0.58) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL5294132 1.00 MEN1 (0.58) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL5284441 1.00 MEN1 (0.58) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL407576 1.00 MEN1 (0.58) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL5294758 1.00 MEN1 (0.58) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12291506-B2 Method for producing amidate compound, and amidate compound KOEI CHEMICAL COMPANY, LIMITED (JP) 2025-05-06 US disclosed
US-20220048864-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND KOEI CHEMICAL COMPANY, LIMITED (JP) 2022-02-17 US disclosed
EP-3858817-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND Koei Chemical Company, Limited (JP) 2021-08-04 EP disclosed
CN-112703184-A Process for producing amide compound, and amide compound 广荣化学株式会社 2021-04-23 CN disclosed
WO-2020067431-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND 広栄化学工業株式会社 2020-04-02 WO disclosed
WO-2007006418-A1 IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-01-18 WO disclosed
WO-2006131234-A1 COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12291506-B2 Method for producing amidate compound, and amidate compound NAAA, NIT2, PAM MEN1 55/4885HSP90AA1 4241/4885KMT2A 4207/4885
US-20220048864-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND NAAA, NIT2, PAM MEN1 55/4885HSP90AA1 4241/4885KMT2A 4207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.